HBW US Executive Decisions: Engle Leaves FTC, Changes At Nature's Bounty, CRN And Benev

Mary Engle led FTC enforcement actions including against POM Wonderful’s claims for its pomegranate supplements; Huber is CRN’s scientific and regulatory affairs VP and Amanda Darlington is government relations director; Jones takes charge of Nature’s Bounty supply chain; and Benev Co. names five aesthetic experts to Medical Advisory Board to advance its “medically developed cosmeceutical line.”

Handshake of businessmen

Mary Engle is retiring from the Federal Trade Commission after 30 years, including serving as the Division of Advertising Practices associate director introducing and explaining commission regulations on responsibilities for dietary supplement and other consumer product firms to support advertising claims. The commission on 21 January said Engle since 2001 has been associate director in the Bureau of Consumer Protection’s advertising practices unit. In that post, she oversaw the bureau’s work regarding national advertising policy and law enforcement, including claims made about food, supplements, alcohol, tobacco and broadband as well as digital technology marketing practices, such as native advertising and influencer marketing.

Engle has led FTC enforcement actions including against POM Wonderful LLC’s claims and other advertising for its pomegranate supplements. (Also...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Leadership

HI-Leadership (Premium-2): Melatonin, Omega 3 & Dietary Supplements: ADHD Hype or Help?

 
• By 

Two experts examine whether melatonin, omega-3, dietary supplements, vitamins, and minerals truly benefit adults with ADHD. While some supplements show promise in supporting brain health, scientific evidence for their effectiveness in improving ADHD symptoms remains limited.

Dermapharm Makes Changes To Turn Around Arkopharma’s Performance

 
• By 

Intensified competition in the dietary supplements market and consumers squeezed by cost-of-living pressures held back sales at Dermapharm's Arkopharma subsidiary in the first half. A leadership change, along with a renewed focus on commercial excellence, is hoped by Dermapharm to turn the business around.

‘Inside Regulatory Affairs’ With Kenvue's Kevin Whelan

This HBW Insight series profiles regulatory affairs specialists working in or supporting the consumer health and beauty product industries. In this installment, we speak to Kenvue's Kevin Whelan.

Estee Lauder Companies’ Freda To Exit In 2025 With Dreary Forecast For Fiscal New Year

 

The beauty giant expects organic sales growth for fiscal 2025 to range between -1% and 2%, falling well short of analyst consensus of 7.2%, reflecting the firm’s overexposure in China and Asia travel retail. A new CEO is incoming with Fabrizio Freda set to step down in June 2025.

More from HBW Insight

data

Type:DataArticle | Publication:HBW | Section:Health | Paywall:Premium — Article containing all Composer content for testing (Do not update)

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.

Test: PDF Link Lifetime

Description description

headline test

description